NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.

导出 OA

翻译打印收藏纠错

作者： Elena,Sultova ^[1] ; C Benedikt,Westphalen ^[2] ; Andreas,Jung ^[3] ; Joerg,Kumbrink ^[3] ; Thomas,Kirchner ^[3] ; Doris,Mayr ^[3] ; Martina,Rudelius ^[3] ; Steffen,Ormanns ^[3] ; Volker,Heinemann ^[2] ; Klaus H,Metzeler ^[2] ; Philipp A,Greif ^[2] ; Alexander,Burges ^[1] ; Fabian,Trillsch ^[4] ; Sven,Mahner ^[1] ; Nadia,Harbeck ^[4] ; Rachel,Wuerstlein ^[1]

作者单位： Department of Obstetrics and Gynecology and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. ^[1] Department of Internal Medicine III and CCC Munich LMU, University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. ^[2] Institute of Pathology and CCC Munich LMU, University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. ^[3] Gynecologic Oncology Center and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. ^[4] Breast Center and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. ^[5] Department of Obstetrics and Gynecology and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. Rachel.Wuerstlein@med.uni-muenchen.de. ^[6] Gynecologic Oncology Center and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. Rachel.Wuerstlein@med.uni-muenchen.de. ^[7] Breast Center and CCC Munich LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. Rachel.Wuerstlein@med.uni-muenchen.de. ^[8]

关键词 Biomarker Breast cancer Molecular diagnostic Molecular tumor board Ovarian cancer Personalized medicine